CFR Part 11 Training
Research Library
|
|
DZS Software Solutions
|
The challenges facing our industry to effectively meet the clinical data study standards set out by the Clinical Data Interchange Standards Consortium (CDISC) specifically with regards to the Study Data Tabulation Module (SDTM) and the Analysis Data Model (ADaM) can be daunting. Our ADaM Data Conversion and Reporting Toolkit may be the solution you are looking for to generate all of your safety ...
|
|
|
Parameter Generation & Control, Inc.
|
On the surface, providing a specified humidity and temperature for stability testing may appear easier to achieve than the 5% RH and 2C ICH guidelines would seem to indicate. The ability to control humidity at 2% does not mean that you are safely within the 5% RH tolerance dictated by ICH.
The ability to produce a recording, display, or printout that is within a specified tolerance may not be a ...
|
|
|
Beckloff Associates
|
Before an organization determines if they will integrate new technologies and guidelines into their existing internal business processes, they must understand the overall landscape of what will be impacted. For example, if an organization develops their own drug compounds, the process of taking those compounds to market is expensive (approximately $800 million) and time-consuming (minimum 12 ...
|
|
|
EMD Chemicals Inc.
|
In unstressed cells, p53 is latent and is maintained at low levels by targeted degradation mediated by MDM2. Through its binding to p53, MDM2 can shuttle p53 out of the nucleus into the cytoplasm for degradation. When normal mammalian cells are subjected to stress signals, such as hypoxia, radiation, and chemotherapeutic drugs, p53 is phosphorylated at multiple sites, including those involved in ...
|
|
|
Beckloff Associates
|
FDA's statutory jurisdiction, hence the regulatory obligations governing the design, characterization, production, and commercialization of laboratory developed tests (LDT), is defined in part by two central elements—(a) the degree of risk associated with the use of the device, and (b) the device's intended use.
The development of increasingly more complex and sophisticated in vitro diagnostic ...
|
|
|
|
